HeLa cells |
|||
| C0008001 | Addexbio | One Frozen vial | EUR 455 |
Hela-RFP stable cells |
|||
| SC031-Puro | GenTarget | 2 x 106 cell/ml x 1ml | EUR 775 |
|
Description: RFP expression stable cell line in Hela cells with Puromycin marker. |
|||
Hela-GFP stable cells (Blasticidin) |
|||
| SC034-Bsd | GenTarget | 2 x 106 cell/ml x 1ml | EUR 775 |
|
Description: GFP expression stable cell line in Hela cells with Blasticidin marker. |
|||
Hela-GFP stable cells (Puromycin) |
|||
| SC034-Puro | GenTarget | 2 x 106 cell/ml x 1ml | EUR 775 |
|
Description: GFP expression stable cell line in Hela cells with Puromycin marker. |
|||
Hela-TetR (Puro) stable cells |
|||
| SC035-Puro | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1210 |
|
Description: tetracycline repressor expression Hela stable cell line with Puromycin marker |
|||
Luciferase (firefly), Hela stable cells (Blasticidin) |
|||
| SC032-Bsd | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1210 |
|
Description: Luciferase (firefry) expression stable cell line in Hela cells with Blasticidin marker. |
|||
Luciferase (firefly), Hela stable cells (Puromycin) |
|||
| SC032-Puro | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1210 |
|
Description: Luciferase (firefry) expression stable cell line in Hela cells with Puromycin marker. |
|||
Hela-rtTA (GFP-Bsd) stable cells |
|||
| SC038-GB | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1645 |
|
Description: rtTA (reverse tetracycline Transcriptional Activator) expression Hela stable cell line with GFP-Blasticidin fusion dual marker |
|||
Hela-rtTA (GFP-Puro) stable cells |
|||
| SC038-GP | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1645 |
|
Description: rtTA (reverse tetracycline Transcriptional Activator) expression Hela stable cell line with GFP-Puromycin fusion dual marker |
|||
Hela-rtTA (RFP-Bsd) stable cells |
|||
| SC038-RB | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1645 |
|
Description: rtTA (reverse tetracycline Transcriptional Activator) expression Hela stable cell line with RFP-Blasticidin fusion dual marker |
|||
HeLa Nuclear Extract (Epithelioid carcinoma cells) |
|||
| NHELA-100 | Alpha Diagnostics | 100 ug | EUR 164 |
HeLa Nuclear Extract (Epithelioid carcinoma cells) |
|||
| NHELA-50 | Alpha Diagnostics | 50 ug | EUR 128 |
PRICE DROP |
|||
| 110-012 | GeneOn | 4 x 1000 µl | EUR 133 |
PRICE DROP |
|||
| 110-012L | GeneOn | 5x 4 x 1000 µl | EUR 518 |
PRICE DROP |
|||
| 110-012XL | GeneOn | 10x 4 x 1000 µl | EUR 939 |
Luciferase-2A-GFP, Hela stable cells (Blasticidin) |
|||
| SC032-GB | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1790 |
|
Description: Luciferase (firefry) and GFP co-expression stable cell line in Hela cells with Blasticidin marker. |
|||
Luciferase-2A-GFP, Hela stable cells (Neomycin) |
|||
| SC032-GN | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1790 |
|
Description: Luciferase (firefry) and GFP co-expression stable cell line in Hela cells with Neomycin marker. |
|||
Luciferase-2A-GFP, Hela stable cells (Puromycin) |
|||
| SC032-GP | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1790 |
|
Description: Luciferase (firefry) and GFP co-expression stable cell line in Hela cells with Puromycin marker. |
|||
Luciferase-2A-RFP, Hela stable cells (Blasticidin) |
|||
| SC032-RB | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1790 |
|
Description: Luciferase (firefry) and RFP co-expression stable cell line in Hela cells with Blasticidin marker. |
|||
Luciferase-2A-RFP, Hela stable cells (Neomycin) |
|||
| SC032-RN | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1790 |
|
Description: Luciferase (firefry) and RFP co-expression stable cell line in Hela cells with Neomycin marker. |
|||
Luciferase-2A-RFP, Hela stable cells (Puromycin) |
|||
| SC032-RP | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1790 |
|
Description: Luciferase (firefry) and RFP co-expression stable cell line in Hela cells with Puromycin marker. |
|||
HeLa Lysate |
|||
| 1201 | ProSci | 0.1 mg | EUR 191 |
|
Description: HeLa lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The HeLa lysate was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
iPSC (iPSC from Blood Cells; Male, Master Lines for Neural Differentiation) *Academic Price |
|||
| ASE-9109 | Applied StemCell | 1 vial (1 x 10^6) | EUR 1568.75 |
|
Description: 12 month |
|||
iPSC (iPSC from Blood Cells; Feale, Master Lines for Neural Differentiation) *Academic Price |
|||
| ASE-9110 | Applied StemCell | 1 vial (1 x 10^6) | EUR 1568.75 |
|
Description: 12 month |
|||
HeLa Antigen Concentrate |
|||
| F813X | Cygnus Technologies | 1 ml | EUR 527 |
|
Description: HeLa Antigen Concentrate by Cygnus Technologies is available in Europe via Gentaur. |
|||
Chang Liver (HeLa) |
|||
| C0050007 | Addexbio | One Frozen vial | EUR 543 |
Human ; HeLa (#1) |
|||
| 02-723 | Sceti | 100ng | EUR 401 |
|
Description: The Human ; HeLa (#1) is available in Europe and for worldwide shipping via Gentaur. |
|||
Hela Nuclear Extract |
|||
| X12001 | EpiGentek | 1000 µg | Ask for price |
|
Description: fast delivery possible |
|||
HeLa Nuclear Extract |
|||
| 1641-01 | Biovision | EUR 185 | |
HeLa Nuclear Extract |
|||
| 1641-1 | Biovision | EUR 338 | |
HeLa Cell Extract |
|||
| 30R-AG012 | Fitzgerald | 100 ug | EUR 349 |
|
Description: Glutathiolated human epithelial carcinoma cell (HeLa) extract |
|||
HeLa Cell Slide |
|||
| 17-001 | ProSci | 1 pack | EUR 180.5 |
|
Description: HeLa S3 (cervix; adenocarcinoma) |
|||
HeLa Membrane Lysate |
|||
| XBL-10439 | ProSci | 0.1 mg | EUR 516.5 |
|
Description: Hela (Human cervix Adenocarcinoma) cell membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The Hela (Human cervix Adenocarcinoma) cell was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated Hela (cervix Adenocarcinoma) cell membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated Hela (cervix Adenocarcinoma) cell membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
|||
HeLa HCP ELISA Kit |
|||
| F810 | Cygnus Technologies | 1 kit (96 wells plate) | EUR 1080 |
|
Description: HeLa HCP ELISA Kit by Cygnus Technologies is available in Europe via Gentaur. |
|||
Anti-HeLa: HRP Conjugate |
|||
| F811 | Cygnus Technologies | 12 ml | EUR 565 |
|
Description: Anti-HeLa: HRP Conjugate by Cygnus Technologies is available in Europe via Gentaur. |
|||
HeLa/GFP Cell Line |
|||
| AKR-213 | Cell Biolabs | 1 vial | EUR 572 |
|
Description: HeLa/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
HeLa/Cas9 Cell Line |
|||
| AKR-5111 | Cell Biolabs | 1 vial | EUR 572 |
Human HeLa cells (Heat shocked) total protein lysate for western control for hsps |
|||
| HSP704-C | Alpha Diagnostics | 100 ul | EUR 286 |
Human Hela Whole Cell Lysate |
|||
| LYSATE0023 | BosterBio | 200ug | EUR 150 |
|
Description: This cell lysate is prepared from human hela using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
HeLa HCP Std. A-H |
|||
| F813 | Cygnus Technologies | 1 ml | EUR 488 |
|
Description: HeLa HCP Std. A-H by Cygnus Technologies is available in Europe via Gentaur. |
|||
Anti-HeLa HCP, Affinity Purified |
|||
| HL59/73-AF | Cygnus Technologies | 1 mg | EUR 1913 |
|
Description: Anti-HeLa HCP, Affinity Purified by Cygnus Technologies is available in Europe via Gentaur. |
|||
HeLa Cell Lysate (Whole Cell) |
|||
| LYSATE0001 | Cusabio | 200ug | EUR 150 |
|
Description: This whole cell lysate is prepared from Hela cells using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
HeLa Nuclear Extract (DTT-free) |
|||
| 7947-01 | Biovision | EUR 185 | |
HeLa Nuclear Extract (DTT-free) |
|||
| 7947-1 | Biovision | EUR 316 | |
Human HeLa cells (normal/non-heat shocked) total protein lysate for western control for hsps |
|||
| HSP703-C | Alpha Diagnostics | 100 ul | EUR 286 |
Inducible GFP Hela stable cell line |
|||
| SC036 | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1500 |
|
Description: InducibleGFP expression stable cell line in Hela cells, with Neomycin and puromycin resitance |
|||
Inducible RFP Hela stable cell line |
|||
| SC037 | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1500 |
|
Description: Inducible RFP expression stable cell line in Hela with Blasticidin and Puromycin resistance |
|||
Hela / Cas9 (Bad) Stable Cell Line |
|||
| SC045-Cas9-Bsd | GenTarget | 2 x 106 cell/ml x 1ml | EUR 1058 |
|
Description: Cas9 expression stable cell line with Blasticidin resistance in Hela human cervical cancer cells. |
|||
Human HeLa-S3 (Cervix Epithelioid Carcinoma) lysate |
|||
| HCL-1201 | Alpha Diagnostics | 100ug | EUR 238 |
Human HeLa Whole Cell Lysate, TNFa Stimulated |
|||
| HCL-2000 | Alpha Diagnostics | 100ug | EUR 213 |
Human HeLa (Cervix Adenocarcinoma) Cell Nuclear Extract |
|||
| HCL-2008 | Alpha Diagnostics | 100ug | EUR 225 |
Human HeLa (Cervix Adenocarcinoma) Whole Cell Lysate |
|||
| HCL-2009 | Alpha Diagnostics | 1 mg | EUR 524 |
HeLa Cell Lysate (Human epithelial Cell Line) |
|||
| LF-R0001 | Abfrontier | 200 ul | EUR 86 |
|
Description: HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate |
|||
cDNA from Human Tumor Cell Line: Hela |
|||
| C1255811 | Biochain | 40 reactions | EUR 376 |
|
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
|||
TARGATT ? Transgenic Kit (5 microinjections) Academic Price *Plasmid sold separately |
|||
| AST-1003 | Applied StemCell | 1 Kit (5 microinjections) | EUR 576.5 |
|
Description: 6 month |
|||
TARGATT ? Transgenic Kit (2 microinjections) Academic Price *Plasmid sold separately |
|||
| AST-1004 | Applied StemCell | 1 Kit (2 microinjections) | EUR 323.38 |
|
Description: 6 month |
|||
Dendritic Cells/B Cells Antibody |
|||
| abx412775-02mg | Abbexa | 0.2 mg | EUR 565 |
anti-CD45 RA B-cells, T-cells, NK-cells |
|||
| 516-A-01mg | Virogen | 0,1 mg | EUR 267.5 |
|
Description: anti-CD45 RA B-cells, T-cells, NK-cells |
|||
anti-CD45 RA B-cells, T-cells, NK-cells |
|||
| 516-A-1000ug | Virogen | 1000 ug | EUR 1282.5 |
|
Description: anti-CD45 RA B-cells, T-cells, NK-cells |
|||
Recombinant Legionella Pneumophila helA Protein (aa 1-1052) |
|||
| VAng-Lsx3644-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Legionella Pneumophila Protein HelA, recombinant protein. |
|||